Peptides: A Scientific Revolution In Modern Medicine

By Dr. Rajesh Sankaranarayanan

GLP-1 peptides are driving a fundamental shift in modern medicine, expanding far beyond their original purpose in diabetes management. By stimulating glucose-dependent insulin secretion, suppressing glucagon, and delaying gastric emptying, these therapies offer powerful mechanisms for weight loss and metabolic control. However, native GLP-1 degrades rapidly in the body due to the DPP-IV enzyme. Modern drug design overcomes this through DPP-IV inhibitors, structural amino acid modifications, and fatty acid side chains that extend therapeutic half-life.

Recent discovery of GLP-1 receptors in the heart, lungs, and kidneys unlocks broader applications, including cardiovascular, renal, and neurodegenerative conditions like Alzheimer's. Next-generation multi-target drugs further amplify these benefits by engaging multiple receptor pathways simultaneously.

Read the full whitepaper to explore the science and therapeutic future of GLP-1 peptides.